Inside KELOLAND: Health and wellness
People in Sioux Falls have the opportunity to join others for a 100-day challenge. The Mayor's Fitness Challenge kicked off its 5th year on April 26th.
'The last four years, we really focused on miles; it was a 100 miles in 100 days is what we encouraged people to do. This year, we are mixing it up a little bit. We are asking people to try and do 100 workouts in 100 days,' Sioux Falls Mayor Paul TenHaken said.
TenHaken says he hopes the change will encourage more people to get involved.
Medical Director for Falls Community Health Dr. Jennifer Tinguely says there are many benefits to exercising.
'Your blood pressure can improve, your cholesterol numbers can improve, you're much less likely to develop a chronic disease like diabetes if you are exercising,' Dr. Tinguely said.
Dr. Tinguely says research shows exercise can also benefit your mental health.
You can find workout trackers and other resources on the Mayor's Fitness Challenge webpage.
Nearly one million people are diagnosed with it every year in the United States. A Sioux Falls woman is sharing her recovery journey after she experienced a blood clot in her lungs.
The role of a Doula is expanding in KELOLAND. They provide information, emotional support, and physical comfort to a mother before, during, and just after childbirth.
Some insurance plans and even Medicaid help cover the cost of hiring one. A Sioux Falls couple is sharing their experience of having a Doula.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Shaker Heights cheerleader released from hospital weeks after leg amputation
SHAKER HEIGHTS, Ohio (WJW) – The Shaker Heights cheerleader whose leg needed to be amputated after an unthinkable diagnosis celebrated a big milestone on Friday. Amani Smith was released from Rainbow Babies and Children's Hospital, weeks after doctors were forced to amputate her left leg. Amani and her family are thrilled to finally be home, but her major life change is only just beginning. The 17-year-old was at cheerleading camp earlier this summer when she started complaining about a stomach ache. Within hours, she was rushed into emergency surgery. Bernie Kosar not giving up as he waits on liver transplant Doctors at the time discovered a ruptured abdominal cyst and an infection led to sepsis, a potentially deadly condition. She had a stroke during surgery and her parents said a nicked artery during the procedure cut off blood flow to her left leg for hours. Doctors were forced to amputate and she was placed on life support for nearly a week. Now, Amani has recovered enough to return home and her family is navigating the next steps as she is determined to dance again. Big Cleveland weekend: What to know about all the events All the while, the Shaker Heights community has rallied around the family. 'It feels really good. I have a good support group around me,' Amani said. 'After two months and a few days, I'm finally free.' Amani is going into her senior year of high school. So far, a GoFundMe page has raised more than $37,000 for the family, who hopes to get her a prosthetic leg. Learn how to donate right here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Axios
9 hours ago
- Axios
Medicaid effort to target undocumented immigrants may create enrollment hurdles
Federal health officials announced a new push on Tuesday to ensure that Medicaid and Children's Health Insurance Program (CHIP) enrollees are U.S. citizens or have a satisfactory immigration status. Why it matters: The effort could create new administrative hoops for enrollees to jump through. Driving the news: The Centers for Medicare and Medicaid Services will begin providing states with "monthly enrollment reports identifying individuals whose citizenship or immigration status could not be confirmed through federal databases," the Department of Health and Human Services said in a statement. The reports will draw on data from sources including the Department of Homeland Security's Systematic Alien Verification for Entitlements (SAVE) program. HHS emphasized that states are responsible for reviewing cases, verifying the immigration status of individuals on the CMS' reports, and "taking appropriate actions." All states will receive these reports within the next month, per the HHS. Reality check: Traditional Medicaid coverage is not available to undocumented immigrants. "Undocumented immigrants are not eligible to enroll in federally funded coverage including Medicaid, CHIP, or Medicare or to purchase coverage through the ACA Marketplaces," per the non-partisan Kaiser Family Foundation. HHS did not respond to Axios' request for comment. What they're saying:"Every dollar misspent is a dollar taken away from an eligible, vulnerable individual in need of Medicaid and CHIP," said CMS Administrator Dr. Mehmet Oz. Between the lines: The change looks to put the burden of proof on the individuals whose immigration statuses the CMS cannot verify through the databases. By the numbers: Despite the assertions of Oz — and other parts of President Trump's administration — there is not evidence that undocumented immigrants are broadly receiving Medicaid benefits they're not eligible for. Medicaid reimburses hospitals for emergency care provided to individuals who meet other eligibility requirements but lack eligible immigration status. Emergency spending rose less than 1% of total Medicaid spending between 2017 and 2023, according to KFF. Immigrants in the country legally may also qualify for Medicaid or CHIP, but face eligibility restrictions. There is a five-year waiting period for these modified forms of Medicaid and CHIP, which states can eliminate for children and pregnant people. An early version of Republicans recently passed tax-and-spending bill would have cut federal payments to states that covered undocumented immigrants with their own funds. The provision was dropped after it was found to violate Senate rules. The White House claimed that the provision would "protect Medicaid for Americans by removing at least 1.4 million illegal immigrants from the program." The other side: The 1.4 million figure "is unequivocally false," according to Georgetown University's Center for Families and Children.
Business Wire
10 hours ago
- Business Wire
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
NEW YORK--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ('TNF' or the 'Company'), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that is has significantly improved its financial position over the past 5 months through a material reduction in liabilities, while maintaining total assets of over $17 million as of June 30, 2025. 'The recent significant improvement in our financial position gives TNF a stronger platform for growth opportunities and taking advantage of shareholder value creation opportunities,' said TNF President and Chief Medical Officer, Mitchell Glass, M.D. 'We are pleased to have the continued support of our largest investors, and look forward to updating investors on TNF's business developments in the near future, including our ongoing collaboration with Renova on GLP-induced inflammation and muscle damage.' The improvements in the Company's financial position will be reflected in future financial statements of the Company. About TNF Pharmaceuticals, Inc. TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. The Company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs. For more information, visit Cautionary Statement Regarding Forward-Looking Statements This press release may contain forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any expected future results, performance, or achievements. Forward-looking statements speak only as of the date they are made and neither the Company nor its affiliates assume any duty to update forward-looking statements. Words such as 'anticipate,' 'believe,' 'could,' 'estimate,' 'expect,' 'may,' 'plan,' 'will,' 'would'' and other similar expressions are intended to identify these forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: unanticipated financial setbacks, the Company needing to pursue financing options that could adversely impact our liabilities due to adverse market conditions, the Company's ability to maintain compliance with the Nasdaq Stock Market's listing standards; the timing of, and the Company's ability to, obtain and maintain regulatory approvals for clinical trials of the Company's pharmaceutical candidates; the timing and results of the Company's planned clinical trials for its pharmaceutical candidates; the amount of funds the Company requires for its pharmaceutical candidates; increased levels of competition; changes in political, economic or regulatory conditions generally and in the markets in which the Company operates; the Company's ability to retain and attract senior management and other key employees; the Company's ability to quickly and effectively respond to new technological developments; and the Company's ability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the Company's proprietary rights. A discussion of these and other factors with respect to the Company is set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed by the Company on April 11, 2025, and subsequent reports that the Company files with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise.
